{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/excellence-pharmacovigilance-solutions-how-fortreas-market-leading-safety-support-enabled#webpage",
"url": "https://www.fortrea.com/insights/excellence-pharmacovigilance-solutions-how-fortreas-market-leading-safety-support-enabled",
"name": "Excellence in pharmacovigilance solutions: How Fortrea’s market-leading safety support enabled global operations for a leading pharmaceutical company",
"description": "This Fortrea case study highlights how pharmacovigilance service providers deliver end-to-end pharmacovigilance services to support global pharmacovigilance operations across the product lifecycle, from clinical trial safety services to post-marketing safety surveillance. Managing drug safety at scale requires robust systems for ICSR case processing in pharmacovigilance, consistent safety data handling, and alignment with evolving regulatory requirements across regions. The case study demonstrates how integrated CRO pharmacovigilance services and scalable global infrastructure enable efficient safety reporting, improved signal detection, and strong pharmacovigilance regulatory compliance. By delivering specialized drug safety services in pharmacovigilance, the approach supports high-quality global operations, helping organizations manage risk, maintain compliance, and ensure patient safety across both clinical development and post-approval phases."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Excellence in pharmacovigilance solutions: How Fortrea’s market-leading safety support enabled global operations for a leading pharmaceutical company",
"item": "https://www.fortrea.com/insights/excellence-pharmacovigilance-solutions-how-fortreas-market-leading-safety-support-enabled"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/excellence-pharmacovigilance-solutions-how-fortreas-market-leading-safety-support-enabled#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/excellence-pharmacovigilance-solutions-how-fortreas-market-leading-safety-support-enabled#webpage"
},
"headline": "Excellence in pharmacovigilance solutions: How Fortrea’s market-leading safety support enabled global operations for a leading pharmaceutical company",
"description": "This Fortrea case study highlights how pharmacovigilance service providers deliver end-to-end pharmacovigilance services to support global pharmacovigilance operations across the product lifecycle, from clinical trial safety services to post-marketing safety surveillance. Managing drug safety at scale requires robust systems for ICSR case processing in pharmacovigilance, consistent safety data handling, and alignment with evolving regulatory requirements across regions. The case study demonstrates how integrated CRO pharmacovigilance services and scalable global infrastructure enable efficient safety reporting, improved signal detection, and strong pharmacovigilance regulatory compliance. By delivering specialized drug safety services in pharmacovigilance, the approach supports high-quality global operations, helping organizations manage risk, maintain compliance, and ensure patient safety across both clinical development and post-approval phases.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-07/fortrea-pharmacovigilance-solutions-global-operations.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-30",
"dateModified": "2025-07-30",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-11/CS%200036%20Exceeding%20Challenging%20Milestones%200723%20HiRes%20%281%29.pdf",
"encodingFormat": "application/pdf"
}
}
]
}